- Tolvaptan in patients with autosomal dominant polycystic kidney disease. Commentary on: NEJM 2012,Torres:Tolvaptan in patients with autosomal dominant polycystic kidney disease2012 | First Faculty of Medicine
- Autosomal dominant spinocerebellar ataxias2005 | Second Faculty of Medicine
- Autosomal dominant spinocerebellar ataxias: Review2018 | Faculty of Medicine in Pilsen
- Autosomal Dominant Tubulointerstitial Kidney Disease2017 | First Faculty of Medicine
- Autosomal recessive and X-linked ataxia2007 | Second Faculty of Medicine
- Autosomal dominant tubulointerstitial kidney disease: A review2022 | First Faculty of Medicine
- Spinocerebellar ataxias. Part II. Problematics of autosomal dominant spinocerebellar ataxias2001 | Second Faculty of Medicine
- The Pendred syndrome - the remarks to autosomal reesive hearing loss associated with goitr2004 | Faculty of Physical Education and Sport
- Autosomal Recessive and Dominant Polycystic Kidney Disease1999 | First Faculty of Medicine, Second Faculty of Medicine
- Hypomagnesaemia is absent in children with autosomal dominant polycystic kidney disease2019 | Second Faculty of Medicine
- The Correlation of Genotype and Phenotype in Children with Autosomal Dominant Polycystic Kidney DiseasePublication without faculty affiliation
- Autosomal dominant tubulointerstitial kidney disease: more than just HNF1 beta2022 | First Faculty of Medicine
- Molecular Genetic Background of an Autosomal Dominant Hypercholesterolemia in the Czech Republic2017 | First Faculty of Medicine
- Autosomal dominant polycystic kidney disease from urological point of view2023 | Faculty of Medicine in Hradec Králové
- Proteinuria in children with autosomal dominant polycystic kidney disease2018 | Second Faculty of Medicine
- Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment2022 | First Faculty of Medicine
- New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease2009 | First Faculty of Medicine
- Spanish guidelines for the management of autosomal dominant polycystic kidney disease2015 | First Faculty of Medicine
- New European recommendations for the treatment with tolvaptan in patients with autosomal dominant polycystic kidneys2021 | First Faculty of Medicine
- DNA analysis of autosomal polycystic kidney disease in Czech Republic2001 | Faculty of Physical Education and Sport
- Genotype phenotype spectrum of PYCR1-related autosomal recessive cutis laxa2013 | Second Faculty of Medicine
- M TOR inhibitor everolimus in patients in with autosomal dominant polycystic kidney disease.Commentary on:NEJM 363,20102010 | First Faculty of Medicine
- Quality of life in patients with autosomal dominant tubulointerstitial kidney disease2019 | First Faculty of Medicine
- Maternal health and pregnancy outcomes in autosomal dominant tubulointerstitial kidney disease2023 | First Faculty of Medicine
- Genotype–phenotype correlation in children with autosomal dominant polycystic kidney disease2009 | First Faculty of Medicine
- Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)2020 | Second Faculty of Medicine
- Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease2018 | First Faculty of Medicine
- Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele2013 | First Faculty of Medicine
- Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease2006 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations2020 | First Faculty of Medicine